Table 1.

Baseline demographic and characteristics before and after the third mRNA-1273 dose

Characteristics	All (n=90)
Age (years), median (IQR)	31 (26-44)
Gender, n (%)
Female	79 (88)
Male	11 (12)
Analysis before third dose
Days after second vaccine, median (IQR)	144 (142-146)
Total antibodies titers, median (IQR), U/mL	41.7 (22.4-92.5)
The positivity anti-S antibodies, n (%)
≥ 0.8 U/mL	90 (100%)
> 210 U/mL	10 (11%)
Analysis after third dose
Days after second vaccine, median (IQR)	236 (234-237)
Days after third vaccine, median (IQR)	57 (44-60)
Total antibodies titers, median (IQR), U/mL	28 394 (20 837-41 646)
The positivity anti-S antibodies, n (%)
≥ 0.8 U/mL	90 (100%)
> 210 U/mL	90 (100%)
Interval between second and third dose (days), median (IQR)	178 (176-191)

IQR = interquartile range